Latest NewsApr 29, 2025HiFiBiO Therapeutics to Present Preclinical Data for A Novel Immunology Antibody at the 2025 Annual Meeting of the Clinical Immunology Society All Filter By: Year20252024202320222021202020192018201720162015Jan 6, 2023HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200603Life Science Success Podcast | Podcast | Jan 5, 2023HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Life Science Success PodcastNov 18, 2022HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate HFB200603 in Combination with Tislelizumab in Patients with DIS® Selected Advanced Solid TumorsSep 5, 2022HiFiBiO Therapeutics to Present Trial in Progress Poster for HFB301001 at 2022 ESMO CongressAug 15, 2022HiFiBiO Therapeutics Announces Clinical Trial Supply Agreement to Evaluate HFB200301 in Combination with Tislelizumab in Patients with DIS® Selected Advanced Solid Tumors< 1 … 3 4 5 6 7 … 17 >
